Preferred Label : erythromycin ethylsuccinate;
MeSH definition : A macrolide antibiotic, produced by Streptomyces erythreus. This compound is an ester
of erythromycin base and succinic acid. It acts primarily as a bacteriostatic agent.
In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal
subunits. This binding process inhibits peptidyl transferase activity and interferes
with translocation of amino acids during translation and assembly of proteins.;
MeSH synonym : eyrthromycin ethyl succinate; ethylsuccinate, erythromycin; ethyl succinate, eyrthromycin; succinate, eyrthromycin ethyl;
CISMeF synonym : erythromycin ethyl succinate;
MeSH hyponym : EryPed; pediamycin; erythroped; monomycin; E-Mycin E; wyamycin E; EMycin E;
MeSH CAS label : erythromycin, 2'-(ethyl butanedioate);
MeSH Related Number : 1264-62-6 (Erythromycin ethylsuccinate);
Registry Number MeSH : 1264-62-6;
Wikipedia link : https://en.wikipedia.org/wiki/Erythromycin ethylsuccinate;
Codes EINECS : 215-033-8;
Is substance : O;
UNII : 1014KSJ86F;
InChIKey : NSYZCCDSJNWWJL-YXOIYICCSA-N;
Origin ID : D015643;
UMLS CUI : C0014810;
Allowable qualifiers
Automatic exact mappings (from CISMeF team)
CISMeF manual mappings
Currated CISMeF NLP mapping
Pharmacological action(s)
Record concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
A macrolide antibiotic, produced by Streptomyces erythreus. This compound is an ester
of erythromycin base and succinic acid. It acts primarily as a bacteriostatic agent.
In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal
subunits. This binding process inhibits peptidyl transferase activity and interferes
with translocation of amino acids during translation and assembly of proteins.
http://www.has-sante.fr/portail/jcms/c_1739166/fr/pediazole
http://www.has-sante.fr/portail/jcms/c_399647/fr/pediazole-granule-pour-sirop-flacon-de-200-ml
2014
false
false
false
France
French
evaluation of the transparency committee
acetyl sulfisoxazole
drug combinations
administration, oral
insurance, health, reimbursement
MK 0641
erythromycin ethylsuccinate
anti-bacterial agents
sulfonamides, combinations with other antibacterials (excl. trimethoprim)
treatment outcome
otitis media
acute disease
haemophilus infections
haemophilus influenzae
child
Otitis media acute
antibiotic therapy
acetyl sulfisoxazole
erythromycin
sulfisoxazole
drug combinations
sulfisoxazole
---
http://www.lecrat.eu/?s=Erythromycine
2012
France
French
antibiotic therapy
pregnancy
erythromycin
erythromycin ethylsuccinate
erythromycin lactobionate
infusions, intravenous
erythromycin
drug information
anti-bacterial agents
erythromycin
---